International
Apr. 15, 2016
Biotech companies turn to International Trade Commission
In recent years, chemical and life sciences companies have increasingly turned to the commission as a forum for patent enforcement. By Adam Lewin, Ewa M. Davison and Bryan Kohm
With the decline of the smartphone wars, patent enforcement activity at the International Trade Commission has dropped by nearly half since its all-time high in 2012. But in the meantime, chemical and life sciences companies have increasingly turned to the commission as a forum for patent enforcement. Indeed, the past several years have been the busiest ever in the life sciences. For example, 2013...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In